R&D Systems™ Recombinant Human Wnt/RSPO3 Agonist Protein, CF

Catalog No.	Quantity
BTWRSP301M	1 mg
BTWRSP3050	50 μg
BTWRSP3100	100 μg
BTWRSP3500	500 μg

Catalog No. BTWRSP301M Supplier R&D Systems™ Supplier No. BTWRSP301M

Description

Recombinant Protein

Measured by its ability to activate TCF reporter activity in HEK293 human embryonic kidney cells. The ED50 for this effect is 7.50-90.0 ng/mL.

Specifications

• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Molecular Weight (g/mol): 83-98 kDa, under reducing conditions.
• Quantity: 1 mg
• Source: Chinese Hamster Ovary cell line, CHO-derived human Wnt/RSPO3 protein Proprietary
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: CRISTIN1, Protein with TSP type-1 repeat, PWTSR, roof plate-specific spondin-3, RSPO 3, R-spondin 3 homolog, R-spondin-3, Thrombospondin type-1 domain-containing protein 2, THSD2, Wnt
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500μg/mL in PBS.
• Form: Lyophilized
• Protein: Wnt/RSPO3